Biodiversity Research, Bioprospecting and Commercialization: Science, Markets and Access and Benefit-Sharing

Author:   Sarah Laird (People and Plants International, Vermont, USA) ,  Rachel Wynberg (University of Cape Town, South Africa)
Publisher:   Taylor & Francis Ltd
ISBN:  

9781138779099


Pages:   256
Publication Date:   31 July 2018
Format:   Paperback
Availability:   Not yet available   Availability explained
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.

Our Price $158.27 Quantity:  
Add to Cart

Share |

Biodiversity Research, Bioprospecting and Commercialization: Science, Markets and Access and Benefit-Sharing


Add your own review!

Overview

The access and benefit-sharing (ABS) policy process of the Convention on Biological Diversity (CBD), and wider discussions about the ethical and conservation issues arising from the commercial use of biodiversity and traditional knowledge, depend upon a well-developed understanding of the activities known broadly as 'bioprospecting'. However, the pace at which our understanding of genetic and other biological resources is accelerating, and market and industry trends are also undergoing constant change. This book provides information and insights into current practices and trends in biodiversity research and bioprospecting, including for potential medicines, food and cosmetics. It presents background information on markets, research and development, and explores recent extraordinary developments in science and technology and their implications for ABS policy development and implementation. The authors present a brief history of the commercial use of biodiversity, and review key trends across sectors. The book continues with chapters devoted to the main industry sectors, including pharmaceuticals and healthcare, agriculture, industrial process biotechnology and food and beverages. Each chapter includes explanatory boxes to describe key technologies and concepts which are less widely understood, as well as input from various stakeholders including industry representatives, NGOs and researchers. It concludes with a review of industry awareness of and engagement with the CBD, ABS and other policy processes. It is an invaluable resource for all concerned with commercial bioprospecting and the implementation of ABS laws and regulations, particularly in light of the adoption of the Nagoya Protocol.

Full Product Details

Author:   Sarah Laird (People and Plants International, Vermont, USA) ,  Rachel Wynberg (University of Cape Town, South Africa)
Publisher:   Taylor & Francis Ltd
Imprint:   Routledge
ISBN:  

9781138779099


ISBN 10:   1138779091
Pages:   256
Publication Date:   31 July 2018
Audience:   College/higher education ,  Postgraduate, Research & Scholarly
Format:   Paperback
Publisher's Status:   Active
Availability:   Not yet available   Availability explained
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.

Table of Contents

Reviews

Author Information

Sarah Laird is Co-director of People and Plants International based in Vermont, USA. Rachel Wynberg is Deputy Director and Senior Researcher at the Environmental Evaluation Unit, University of Cape Town, South Africa.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List